Severity
Moderate
FDA Devices recall · Reported December 12, 2018
The firm received complaints of the wrap coming apart and leaking granular material
Pfizer Inc. recalled Thermacare HEATWRAPS JOINT PAIN THERAPY, 8 HEATWRAPS; MUSCLE PAIN THERAPY, 3 HEATWRAPS a… - a moderate-severity action.
Thermacare HEATWRAPS JOINT PAIN THERAPY, 8 HEATWRAPS; MUSCLE PAIN THERAPY, 3 HEATWRAPS a… was recalled by Pfizer Inc. in December 12, 2018. Reason: The firm received complaints of the wrap coming apart and leaking granular material. Check the official notice for the remedy. Verify recall #Z-0556-2019 with the FDA Devices before acting.
The recall
Pfizer Inc. issued this moderate-severity FDA Devices recall-The firm received complaints of the wrap coming apart and leaking granular material.
Sourced from official FDA Devices enforcement records. Verify recall #Z-0556-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0556-2019) was formally reported on December 12, 2018, with the manufacturer initiating the action on October 2, 2018. It is classified under Moderate severity (Class II), with a current status of Terminated. Pfizer Inc. is listed as the recalling firm, operating out of New York, NY. Federal records list the affected scope as 4956 units.
The documented reason for this recall is: The firm received complaints of the wrap coming apart and leaking granular material Distribution data in the federal record shows the product reached: US Nationwide Distribution and PR. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,422 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
4956 units
Related Recalls
6
0 from same agency
Thermacare HEATWRAPS JOINT PAIN THERAPY, 8 HEATWRAPS; MUSCLE PAIN THERAPY, 3 HEATWRAPS a) UPC 0573301311 b) UPC 0573301311 Product Usage: Provides heat therapy for temporary relief of minor muscular and joint aches and pains associated with overexertion, sprains, and arthritis.
The firm received complaints of the wrap coming apart and leaking granular material
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-0556-2019 |
| Date reported | December 12, 2018 |
| Date initiated | October 2, 2018 |
| Recalling firm | Pfizer Inc. |
| Firm location | New York, NY |
| Affected scope | 4956 units |
| Distribution | US Nationwide Distribution and PR |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-07-02
· 2026-07-02
· 2026-06-25
· 2026-06-25
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported December 12, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.